Valneva SE (VALN) Equity Income (2021 - 2025)
Valneva SE (VALN) posted quarterly Equity Income of -$56.9 million for Q4 2025, down 35.5% year-on-year from -$88.2 million in Q4 2024, and down 12.61% on a QoQ basis from -$50.5 million in Q3 2025.
Valneva SE (VALN) Equity Income (2021 - 2025) Analysis & Trends
Valneva SE (VALN) has reported Equity Income for 3 consecutive years, with -$56.9 million the latest figure, recorded in Q4 2025.
- Quarterly Equity Income fell 35.5% year-over-year to -$56.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$160.0 million (down 204.33% YoY) and the FY2025 annual result came in at -$131.1 million, down 844.26% from the prior year.
- Equity Income eased to -$56.9 million in Q4 2025 per VALN's latest filing, from -$50.5 million in the prior quarter.
- Over the last five years, Equity Income for VALN reached as high as $98.2 million in Q3 2021 and fell as low as -$66.8 million in Q2 2021.
- A 3-year average of -$20.0 million and a median of -$36.8 million in 2021 frame the typical range for Equity Income.
- The largest YoY upside for Equity Income was 35.5% in 2025 against a maximum downside of 377.42% in 2025.
- Year by year, Equity Income stood at $130864.7 in 2021, then slumped by 32186.96% to -$42.0 million in 2024, then slumped by 35.5% to -$56.9 million in 2025.
- According to Business Quant data, Equity Income over the past three periods registered -$56.9 million, -$50.5 million, and -$42.0 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -56.90 Mn |
| Sep 30, 2025 | -50.53 Mn |
| Dec 31, 2024 | -41.99 Mn |
| Sep 30, 2024 | -10.58 Mn |
| Dec 31, 2021 | 130,864.74 |
| Sep 30, 2021 | 98.18 Mn |
| Jun 30, 2021 | -66.80 Mn |
| Mar 31, 2021 | -31.52 Mn |